Patents by Inventor Alberto Bosque-Pardos

Alberto Bosque-Pardos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETING STAT SUMOYLATION TO ENHANCE IMMUNE RESPONSES
    Publication number: 20210114999
    Abstract: The present disclosure generally relates to compositions and methods for ex vivo expansion of immune cells isolated from a subject, wherein gene expression can be modulated to enhance immune cell activity in the resulting expanded immune cell culture. Modulation of gene expression in an expanded immune cell culture allows for an immune cell therapy contains genetically chemically modified immune cells suitable for the adoptive cell transfer into a subject in need thereof.
    Type: Application
    Filed: December 17, 2020
    Publication date: April 22, 2021
    Inventors: Alberto Bosque-Pardos, Amanda Beatriz Rodrigues Barreto De Macedo, Eric S. Sorensen, Vicente Planelles
  • TRIZOL-1-OL ANALOGS ANTI-RETROVIRAL LATENCY DRUGS
    Publication number: 20170360784
    Abstract: In one aspect, the invention relates to triazol-1-ol compounds, analogs thereof, compositions comprising same, and methods of using same, alone or in combination with other agents, to reactivate latent retroviruses, and more particularly to reactivate latent HIV-1. Such compounds, compositions, and methods can be used, for example, in connection with diagnosing and/or treating a retrovirus, and more specifically HIV-1. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: June 30, 2017
    Publication date: December 21, 2017
    Inventors: Vincente Planelles, Alberto Bosque-Pardos, Chris M. Ireland, Ryan Van Wagoner, Mary Kay Harper-Ireland, John Alan Maschek
  • Trizol-1-OL analogs anti-retroviral latency drugs
    Patent number: 9730928
    Abstract: In one aspect, the invention relates to triazol-1-ol compounds, analogs thereof, compositions comprising same, and methods of using same, alone or in combination with other agents, to reactivate latent retroviruses, and more particularly to reactivate latent HIV-1. Such compounds, compositions, and methods can be used, for example, in connection with diagnosing and/or treating a retrovirus, and more specifically HIV-1. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: August 15, 2017
    Assignee: Univeristy of Utah Research Foundation
    Inventors: Vincente Planelles, Alberto Bosque-Pardos, Chris M. Ireland, Ryan Van Wagoner, Mary Kay Harper-Ireland, John Alan Maschek
  • TRIZOL-1-OL ANALOGS ANTI-RETROVIRAL LATENCY DRUGS
    Publication number: 20160151365
    Abstract: In one aspect, the invention relates to triazol-1-ol compounds, analogs thereof, compositions comprising same, and methods of using same, alone or in combination with other agents, to reactivate latent retroviruses, and more particularly to reactivate latent HIV-1. Such compounds, compositions, and methods can be used, for example, in connection with diagnosing and/or treating a retrovirus, and more specifically HIV-1. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: June 13, 2014
    Publication date: June 2, 2016
    Inventors: Vincente Planelles, Alberto Bosque-Pardos, Chris M. Ireland, Ryan Van Wagoner, Mary Kay Harper-Ireland, John Alan Maschek